Clinical trial

Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By…

NCT00041275 · National Medical Research Council (NMRC), Singapore, Other · Completed

Key facts

NCT number NCT00041275
Title Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Official title Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma
Lead sponsor National Medical Research Council (NMRC), Singapore, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Liver Cancer
Intervention type Drug
Interventions megestrol acetate
Enrollment 300
Start date May 1, 2002
Primary completion Jun 1, 2007
Completion Aug 1, 2011
First posted Jan 28, 2003
Last update posted Sep 20, 2013
Countries Bangladesh, Burma, Indonesia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies